Filed Sept. 23, 2026

Serial No. 50124721

Examining Attorney null

Class Pharmaceutical preparations for the treatment of neurological, neuromuscular, and musculoskeletal disorders including muscle dystonias, cervical dystonia, blepharospasm, upper limb spasticity, cerebral palsy, muscle spasms, muscle tremors, smooth muscle disorders, autonomic nerve disorders, musculoskeletal disorders, headaches, migraines, pain, hyperhidrosis, excessive sweating, wrinkles, facial wrinkles, dynamic facial wrinkles, facial lines, glabellar lines, frown lines, and sports injuries, namely, injuries to skin, muscle, ligaments, or bone; botulinum toxin preparations and peptide-formulated preparations for medical, therapeutic, and aesthetic use; peptide substrates and botulinum toxin for use in the treatment of neurological disorders, neuromuscular disorders, muscle dystonias, cervical dystonia, blepharospasm, upper limb spasticity, cerebral palsy, muscle spasms, muscle tremors, smooth muscle disorders, autonomic nerve disorders, musculoskeletal disorders, headaches, migraines, pain, hyperhidrosis, excessive sweating, wrinkles, facial wrinkles, dynamic facial wrinkles, facial lines, glabellar lines, frown lines, and sports injuries, namely, injuries to skin, muscle, ligaments, or bone; analgesic and muscle relaxant pharmaceutical preparations; pharmaceutical preparations for use in dermatology; medicated skin care preparations; medicated body creams, lotions, and gels; and medicated eye creams, lotions, and gels; 005; 006; 018; 044; 046; 051; 052

Case Type Trademark